Search

Author/Creator Rønn Olsen, Lars

1. ATIM-01. NIVOLUMAB AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA; A TRANSLATIONAL TRIAL IN PROGRESS. (11th November 2019)

Authors:
Eibye, Simone; Hasselbalch, Benedikte; Marie Svane, Inge; Reker Hadrup, Sine; Rønn Olsen, Lars; Skjoeth-Rasmussen, Jane; Scheie, David; Østrup, Olga; Skovgaard Poulsen, Hans; Lassen, Ulrik
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment. (31st December 2022)

Authors:
Lecoq, Inés; Kopp, Katharina L.; Chapellier, Marion; Mantas, Panagiotis; Martinenaite, Evelina; Perez-Penco, Maria; Rønn Olsen, Lars; Zocca, Mai-Britt; Wakatsuki Pedersen, Ayako; Andersen, Mads Hald
Journal:
Oncoimmunology
Issue:
Volume 11:Number 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search